Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lapatinib in relapsed esophageal adenocarcinoma
NCT00259987Phase 2Completed
- Sponsor
- GSK
- Start
- Nov 2005
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of lapatinib in esophageal adenocarcinoma (EAC), sponsored by GSK. Started Nov 2005; status: completed.
02
Drugs
lapatinib
03
Conditions
esophageal adenocarcinoma (EAC)
Beyond the preview
Go deeper on NCT00259987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00259987.